Related Experiment Video
Updated: Jun 6, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
Published on: May 24, 2024
Recompensation Following Alcohol-Related Hepatitis Is Associated With Increased Survival: Results From a Multicenter
Jordi Gratacós-Ginès1, Pilar Ruz-Zafra2, Queralt Herms3
1Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain.
Recompensation after alcohol-related hepatitis (AH) is common, especially with abstinence, and improves survival. Predicting recompensation aids in treatment decisions, including liver transplant evaluations.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Medicine
Background:
- The rate of recompensation in alcohol-related hepatitis (AH) survivors is not well-established.
- Understanding recompensation is crucial for managing AH and its long-term consequences.
Purpose of the Study:
- To determine the rate and predictors of recompensation in AH survivors.
- To assess the clinical impact of recompensation on transplant-free survival (TFS).
- To develop adapted criteria for recompensation in AH.
Main Methods:
- A nationwide registry-based study of AH patients discharged between 2014 and 2021.
- Recompensation assessed using Baveno VII and expanded AH liberal-abstinence criteria at 1 and 3 years.
- Landmark analysis evaluated the impact of recompensation on TFS.
Main Results:
- Recompensation rates at 3 years were 14.3% (AH liberal-abstinence) and 8.8% (Baveno VII).
- Absence of prior decompensation, higher baseline alkaline phosphatase, and lower Child-Pugh score predicted recompensation.
- Recompensated patients had significantly higher 5-year TFS (84.9% vs. 47.7%).
Conclusions:
- Recompensation is frequent in AH survivors, particularly with alcohol abstinence.
- Recompensation is a significant predictor of improved long-term survival.
- Identifying patients likely to recompense can inform clinical decisions, including liver transplantation eligibility.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...